Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing the capabilities of its AI platform, GaluxDesign, in de novo antibody design.

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an experimentally resolved structure SEOUL, South Korea, March 17, 2025 ...

That includes DNA, RNA, antibodies, the ligands that bind ... which has just published a blog post on the update. “Experimental protein-structure prediction can take about the length of a ...

GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

Ten years ago, nobody knew that Asgard archaea even existed. In 2015, however, researchers examining deep-sea sediments ...

CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will ...